Improving Early Detection of Pancreatic Cancer in High-Risk Patients - ASCO Post.
Important study by PRECEDE Consortium.See if you should be screened. precedestudy.org ⁦Diane Simeone⁩ ⁦UC San Diego Health⁩ ascopost.com/news/april-202…

Today at iwCAR-T with international experts to discuss pathways to apply CAR-T and IO to solid tumors (including pancreatic cancer. Amazing discussion. ⁦Diane M. Simeone, MD⁩ @moorescancercenterUCSD

Performance is all about having a great team- special thanks to this team as we move on to UCSD. #PRECEDE

It’s official! It is my absolute privilege to be named as the Director of the Moores Comprehensive Cancer Center at UCSD Health. I am looking forward to advancing efforts in cancer based on an approach of collaboration and excellence.

Thank you A2Bio OncLive.com w. Dr. Marwan G. Fakih to share the important BASECAMP-1 study and EVEREST-1 study to evaluate CAR-T cell therapy in patients without HLA-A*02 expression. #PancreaticCancer #clinicaltrails
onclive.com/view/simeone-a…

I’m thrilled to welcome Dr. Kimryn Rathmell on her 1st day as Director of National Cancer Institute at #NIH . She's the right leader for NCI, a fantastic combination of researcher & clinician who understands the process of translating research to effective cancer treatments. go.nih.gov/8tqjM49

Metabolic syndrome is linked to the incidence of #PancreaticCancer
thelancet.com/journals/eclin…
Large retrospective epidemiological study from 🇯🇵 ( #OpenAccess in eBioMedicine – The Lancet Discovery Science) dovetails nicely into recent mechanistic preclinical data from 🇨🇦 in Cell Metabolism

Privilege to meet Dr Vinciane Rebours, Chair of Pancreatology at Hospital Beaujon in Paris, here at the Semmelweis Symposium in Budapest- the US and France teaming up to understand what causes pancreatic cancer and to detect it early. #PRECEDE #pancreatic cancer #early detection

Integrating genetic and non-genetic determinants of cancer evolution by single-cell multi-omics go.nature.com/2EaExlT #Review by
Anna Nam, Ronan Chaligne (He/Him) & Dan Landau
@NYGenome Weill Cornell Medicine Weill Cornell Medicine Meyer Cancer Center

“I have always imagined that Paradise will be a kind of library.”

— Jorge Luis Borges

These are the best science images of 2023, including cosmic dust, microscopic syrup, a flying gecko and more go.nature.com/486STMw

In Nature this week: Internal clocks – Blood proteins reveal age of human organs to help track health and disease. Browse the full issue here: nature.com/nature/volumes…

A randomized trial to assess weight gain after stopping the GLP-1/GIP drug tirzepatide treatment for obesity
jamanetwork.com/journals/jama/… JAMA Dr. Louis Aronne

#PancreaticCancer & #ArtificialInteligence .
Cao et.al. published a paper in Nature (20Nov23 online) claiming an (AUC) of 0.986–0.996 for detection of pancreatic lesions including adenocarcinoma ( #PDAC ) using non-contrast CT.
BUT, there is a BIG

Annual PRECEDE meeting: honored to have NYT/best selling author Will Schwalbe speak and inspire us in our mission to work together to improve outcomes in pancreatic cancer. Here with Will, Jenny Permuth, Ray Wadlow, and Phil Hart. #PRECEDE

🟣 The PRECEDE Meeting is an annual outstanding event 🟣 Many ideas in the box and brilliant scientists thinking out of the box 🟣 Pancreatic cancer early detection will pass through here! 🕊️🤞🙏PrecedeStudy Fondazione Nadia Valsecchi Onlus Project Purple® Pancreas Verona Diane M. Simeone, MD Università di Verona

This week's The Lancet cover
from thelancet.com/journals/lance…

What an Oncologist Wants You to Know About Pancreatic Cancer katiecouric.com/health/cancer/…

Happening now at 11:00am ET Doctor Radio as I join Dr. Caren Behar in discussion on general pancreatic cancer segment in honor of November being Pancreatic Cancer Awareness Month.

Tune in tomorrow 11:00am ET Doctor Radio as I join Dr. Caren Behar in discussion on general pancreatic cancer segment in honor of November being Pancreatic Cancer Awareness Month.